The Secrets To Improving Patient Access To High-Cost Medications with Julia Regan, co-founder and CEO of RxLightning

Outcomes Rocket

Specialty medications are costly and complex to obtain and make up over 50% of the drug spend in the US.

In this episode, Julia Regan, co-founder and CEO of RxLightning, explains why she created a digital platform that helps patients access high-cost, complex drugs faster and more efficiently. RxLightning's platform supports over 1600 medications, working seamlessly with provider platforms and EHR systems to reduce prescription wait times from weeks to days, ensuring top-quality patient care through a more cohesive experience. Throughout this interview with Saul Marquez, Julia underscores how the company has grown to include 1200 organizations that use its services, leveraging white-labeling to increase adoption. She also emphasizes how, despite financial constraints and the need to balance revenue with value, RxLightning has made significant strides in digitizing prescription processes, ensuring data protection, and improving patient outcomes.

Tune in and learn how RxLightning is transforming the specialty medication landscape and making prescriptions at lightning speed!

Resources:

• Watch the entire interview here.
• Connect and follow Julia Regan on LinkedIn.
• Learn more about RxLighting on their LinkedIn and website.